365 SKINNY High Intensity Capsules — Class I drug recall D-0631-2022
Terminated recall by Je Dois Lavoir LLC, reported 2022-02-23, distributed nationwide. Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramin
| Recall number | D-0631-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Je Dois Lavoir LLC, Visalia, CA, United States |
| Recall initiated | 2021-08-02 |
| Classified | 2022-02-23 |
| Reported by FDA | 2022-02-23 |
| Terminated | 2023-05-02 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA |
| Quantity | 783 bottles |
| Reason classes | undeclared allergen, unapproved product |
| Lot numbers | 102-26 |
| Expiration dates | 2022-12-20 |
Product
365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONAL
Reason for recall
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0631-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.